DE3484244D1 - Herstellung von cdna die hepatitis a virale sequenzen darstellen. - Google Patents
Herstellung von cdna die hepatitis a virale sequenzen darstellen.Info
- Publication number
- DE3484244D1 DE3484244D1 DE8484903735T DE3484244T DE3484244D1 DE 3484244 D1 DE3484244 D1 DE 3484244D1 DE 8484903735 T DE8484903735 T DE 8484903735T DE 3484244 T DE3484244 T DE 3484244T DE 3484244 D1 DE3484244 D1 DE 3484244D1
- Authority
- DE
- Germany
- Prior art keywords
- hepatitis
- cdna
- represent
- production
- viral sequences
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/706—Specific hybridization probes for hepatitis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
- C12N2770/32422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
- C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Animal Behavior & Ethology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53791183A | 1983-09-30 | 1983-09-30 | |
PCT/US1984/001552 WO1985001517A1 (en) | 1983-09-30 | 1984-09-27 | PRODUCTION OF cDNA REPRESENTING HEPATITIS A VIRAL SEQUENCES |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3484244D1 true DE3484244D1 (de) | 1991-04-11 |
Family
ID=24144624
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8484903735T Expired - Fee Related DE3484244D1 (de) | 1983-09-30 | 1984-09-27 | Herstellung von cdna die hepatitis a virale sequenzen darstellen. |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0162054B1 (de) |
JP (1) | JPS61500053A (de) |
DE (1) | DE3484244D1 (de) |
WO (1) | WO1985001517A1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3112338C2 (de) * | 1981-03-28 | 1995-02-23 | Klaus Von Der Helm | Verwendung von Hybridisierungssonden zum Nachweis von HAV |
DE3582812D1 (de) * | 1984-03-02 | 1991-06-20 | Merck & Co Inc | Dns-fragmente welche fuer peptide kodieren, die faehig sind in vivo die synthese von antihepatitis-a-virus-antikoerpern zu induzieren. |
CA1324094C (en) * | 1985-04-03 | 1993-11-09 | Dino Dina | Hepatitis a virus vaccines |
FR2623817B1 (fr) * | 1987-11-26 | 1990-05-04 | Pasteur Institut | Sondes pour la detection d'enterovirus par hybridation moleculaire et pour la discrimination entre des poliovirus et d'autres enterovirus |
US5789559A (en) | 1988-06-17 | 1998-08-04 | Genelabs Technologies, Inc. | DNA sequences of enterically transmitted non-A/non-B hepatitis viral agent |
US5824649A (en) * | 1988-06-17 | 1998-10-20 | Genelabs Technologies, Inc. | DNA sequences of enterically transmitted non-A/non-B hepatitis viral agent and characteristic epitopes thereof |
AU3748489A (en) * | 1988-06-17 | 1990-01-12 | Genelabs Incorporated | Enterically transmitted non-a/non-b hepatitis viral agent |
US5294548A (en) * | 1990-04-02 | 1994-03-15 | American Biogenetic Sciences, Inc | Recombianant Hepatitis a virus |
CN1075112C (zh) * | 1990-04-05 | 2001-11-21 | 基因实验室有限公司 | 制备hev蛋白质和检测hev感染的方法 |
CA2097426A1 (en) * | 1990-11-30 | 1992-05-31 | Bruce M. Cameron, Sr. | Method for the diagnosis of chronic lower back and cervical pain |
HRP950097A2 (en) | 1994-03-08 | 1997-06-30 | Merck & Co Inc | Hepatitis a virus culture process |
EP0904379A2 (de) * | 1996-04-19 | 1999-03-31 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Affen-menschliche hav mit einem chimärischen 2c protein |
US6942965B2 (en) * | 2001-10-12 | 2005-09-13 | Chiron Corporation | Hepatitis A virus nucleotide sequences, recombinant proteins and uses thereof |
CU23202A1 (es) * | 2003-01-31 | 2007-05-18 | Ct Ingenieria Genetica Biotech | ANTIGENOS RECOMBINANTES DEL VIRUS DE LA HEPATITIS A OBTENIDOS EN CéLULAS VEGETALES |
ES2392445T3 (es) | 2004-07-13 | 2012-12-10 | Gen-Probe Incorporated | Composiciones y métodos para la detección de ácido nucleico del virus de la hepatitis A |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL63224A (en) * | 1980-07-17 | 1985-05-31 | Scripps Clinic Res | Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom |
DE3112338C2 (de) * | 1981-03-28 | 1995-02-23 | Klaus Von Der Helm | Verwendung von Hybridisierungssonden zum Nachweis von HAV |
US4719177A (en) * | 1981-04-20 | 1988-01-12 | Massachusetts Institute Of Technology | Production of complementary DNA representing RNA viral sequences by recombinant DNA methods and uses therefor |
DE3582812D1 (de) * | 1984-03-02 | 1991-06-20 | Merck & Co Inc | Dns-fragmente welche fuer peptide kodieren, die faehig sind in vivo die synthese von antihepatitis-a-virus-antikoerpern zu induzieren. |
-
1984
- 1984-09-27 DE DE8484903735T patent/DE3484244D1/de not_active Expired - Fee Related
- 1984-09-27 WO PCT/US1984/001552 patent/WO1985001517A1/en active IP Right Grant
- 1984-09-27 JP JP59503708A patent/JPS61500053A/ja active Pending
- 1984-09-27 EP EP84903735A patent/EP0162054B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0162054A1 (de) | 1985-11-27 |
JPS61500053A (ja) | 1986-01-16 |
EP0162054B1 (de) | 1991-03-06 |
WO1985001517A1 (en) | 1985-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3482828D1 (de) | Herstellung von erythropoietin. | |
ATE72660T1 (de) | Herstellung von zeolith-l. | |
DE3780933D1 (de) | Herstellung von aminoalanen. | |
DE3280246D1 (de) | Cdna representierende rna-virensequenzen. | |
DE3484244D1 (de) | Herstellung von cdna die hepatitis a virale sequenzen darstellen. | |
DE3481568D1 (de) | Herstellung von photodioden. | |
ATE38211T1 (de) | Herstellung von zeolith-l. | |
DE3778134D1 (de) | Kontinuierliche herstellung von dialkansulfonylperoxiden. | |
DE3382074D1 (de) | Herstellung von hydroxyarylaldehyden. | |
DE68923356D1 (de) | Verfahren zur Herstellung von Graphitwhiskern. | |
DE68910310D1 (de) | Hydroformylierungsverfahren zur Herstellung von Aldehyden. | |
DE3584300D1 (de) | Herstellung von malaria-impfstoffen. | |
DE68921340D1 (de) | Herstellung von epoxinitraten. | |
DE3875281D1 (de) | Herstellung von pseudoiononen. | |
FI843960L (fi) | Produktion av magnesium. | |
DE3381907D1 (de) | Herstellung von trifluormethylpyridinen. | |
DE3765485D1 (de) | Herstellung von metallgluconaten. | |
DE3582003D1 (de) | Herstellung von glycolmonoestern. | |
ATE61408T1 (de) | Herstellung von cdna die hepatitis a virale sequenzen darstellen. | |
DE3481522D1 (de) | Herstellung von aminopolyolen. | |
DE3762336D1 (de) | Kontinuierliches herstellungsverfahren von dichlorhydrin. | |
DE69002496D1 (de) | Herstellung von fluorphenolen. | |
DE3869831D1 (de) | Elektrolytische herstellung von chlordioxid. | |
DE3486237D1 (de) | Herstellung von Diacetoxybenzylidendiacetaten. | |
DE3766873D1 (de) | Herstellung von substituierten dichlormethylpyridinen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |